
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Biventricular pacemakers, implantable cardioverter defibrillators (ICDs), pacemakers, and cardiac loop recorders are a few examples of the Cardiovascular Medical Devices that are used to monitor or control irregular heartbeats in patients with specific heart rhythm problems and heart failure.
Make a Time Appointment. Choose the treatment you require from our specialists. Schedule & Find a Doctor. Your doctor may advise that you get one of these devices if you have been diagnosed with bradycardia, ventricular arrhythmia, or a supraventricular arrhythmia like atrial fibrillation and atrial flutter.
The device starts gathering data on your cardiac rhythm as soon as it is implanted. Our cardiac device team receives this data wirelessly, either automatically, through pre scheduled transfers, or manually, when you experience symptoms, remote observation.
Two different types of pacemakers exist. The conventional type is inserted beneath the skin and uses electronic leads to link to the heart. A smaller pacemaker that doesn't require transvenous leads is implanted inside the heart.
Bradycardia, a disorder where the heart beats too slowlyâless than 60 beats per minuteâis treated using pacemakers. The pacemaker generates electrical pulses that maintain a regular heartbeat.
In order to resynchronize the contractions of the left lower chambers of the heart, or ventricles, a biventricular pacemaker functions similarly to a conventional pacemaker but uses a third wire to transmit electrical impulses to the heart.
A biventricular pacemaker, also known as a cardiac resynchronization device, is placed when drugs for heart failure, a condition in which the heart does not pump enough blood to the body and when the left chamber does not beat in unison, do not improve symptoms.
The two ventricles start contracting at different times as a result of this. The contractions of the left ventricle are coordinated by a resynchronization device.
The Oman Cardiovascular Medical Devices market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The Oman Cardiovascular Medical Devices market is fueled by an increase in the prevalence of heart conditions, an aging population that is on the rise and is particularly sensitive to coronary heart conditions, and increased device efficiency.
The prevalence of heart disorders is particularly high in Oman. Due to the growing incidence rate of cardiovascular diseases and the need to reduce mortality by treating cardiovascular disease early on with the use of cardiac monitoring technologies, the rate of cardiovascular disease diagnosis is rising over time.
Due to the rising prevalence of cardiovascular disorders and technological improvements, the ECG monitor segment is anticipated to contribute significantly to the Oman Cardiovascular Medical Devices market growth over the coming years.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |